CytoSorbents Corporation (CTSO) Actualités

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering

Oversubscribed Rights Offering Generated $6.25 Million in Aggregate Gross Proceeds Offering Proceeds Satisfies...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

PRINCETON, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the...

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin...

Form 8-K - Current report

CytoSorbents Rights Offering Begins

PRINCETON, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO) announces the...

Form 4 - Statement of changes in beneficial ownership of securities